nms-1116354
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2009 (NCT01016327)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
CDC7 inhibitor
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3545321 ↗
Also known as
- nms-1116354
- nms-1116354
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01092052 | Phase 1 | Jan 1, 2010 | Institut Gustave Roussy, Nerviano Medical Sciences |
| NCT01016327 | Phase 1 | Apr 1, 2009 | Nerviano Medical Sciences, South Texas Accelerated Research Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Nerviano Medical Sciences | For profit | 2 | 2 | 1 | 2009 |
| Institut Gustave Roussy | Academic/Hospital | 1 | 0 | 1 | 2010 |
| South Texas Accelerated Research Therapeutics | For profit | 1 | 0 | 1 | 2009 |
3 organizations
Page 1 / 1